Related Experiment Video

Updated: Aug 20, 2026

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

Cardiogenic shock: a lethal complication of acute myocardial infarction

David R Holmes1

  • 1Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Reviews in Cardiovascular Medicine
|September 2, 2003
PubMed

Insights

Cardiogenic shock, a severe myocardial infarction complication, is best treated with revascularization over medical therapy. Adjunctive therapies like intra-aortic balloon pump counterpulsation can improve outcomes.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock complicates myocardial infarction (MI) in ~7% of patients, causing most infarction-related deaths.
  • It stems from extensive left ventricular damage, characterized by hypotension and hypoperfusion.
  • ST-segment elevation MI (STEMI) patients experience shock more frequently than non-STEMI patients.

Purpose of the Study:

  • To review the management of cardiogenic shock post-myocardial infarction.
  • To highlight the benefits of revascularization and adjunctive therapies.

Main Methods:

  • Literature review of studies on cardiogenic shock in myocardial infarction.
  • Analysis of treatment outcomes comparing revascularization with medical therapy.
  • Evaluation of adjunctive therapies including vasopressors, mechanical support, and intra-aortic balloon pump counterpulsation (IABP).

Main Results:

  • Revascularization (angioplasty or bypass surgery) yields better outcomes than intensive medical therapy for shock.
  • Intra-aortic balloon pump counterpulsation (IABP) can stabilize patients and facilitate safer revascularization.
  • Investigational therapies include advanced mechanical support, hypothermia, and supersaturated oxygen.

Conclusions:

  • Revascularization is the preferred treatment strategy for cardiogenic shock following MI.
  • Adjunctive therapies, particularly IABP, play a crucial role in patient stabilization and procedural safety.
  • Ongoing research explores novel treatments to further improve survival rates.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...